Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

The conclusion is that using the 5W1H method can improve diagnosis and management of childhood hair-pulling disorder.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

About 61% of women who had COVID-19 experienced hair loss afterward.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Combining fractional CO2 laser with topical dutasteride is more effective for treating male hair loss than using the laser alone.

Long-hair follicular unit excision improves hairline restoration results and patient satisfaction.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

Hair transplants can work for permanent hair loss if the condition is stable and done carefully.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

People with androgenetic alopecia have a higher risk of heart disease.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Nivolumab can cause hair loss as a rare side effect.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.